Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Knightscope
Sponsored
content by Knightscope
MA
MarketJar
Community Contributor
The Next Phase of Defense AI: A Robotic Response to America’s Security Gaps
Autonomous systems are no longer just a futuristic vision — they’re fast becoming an essential layer of national security. As AI reshapes everything from finance to warfare, physical security remains one of the most under-addressed frontiers.
View narrative
US$12.00
FV
51.2% undervalued
intrinsic discount
22.00%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
1
users have commented on this narrative
17
users have followed this narrative
New
narrative
Figma
TI
TickerTickle
Community Contributor
Figma (FIG): The S&P 500’s Design Standard Turning Into an All-in-One Platform
Watching Figma Grow Up I’ve been using Figma almost every single day for the past five years. As a product designer, it’s been my main tool for designing interfaces, testing and prototyping ideas, and also for working together with teams in different countries and time zones.
View narrative
US$65.70
FV
6.7% overvalued
intrinsic discount
30.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
Updated
narrative
Sleep Cycle
MA
Mandelman
Community Contributor
Sleep Cycle's Revenue Set to Rise 10% with Strong Revenue Model
Update Q1 2025 (updated 250510) The latest user‐growth data suggest headwinds for top-line revenue, but management’s active repricing initiatives should help offset this. By combining modest user gains with targeted price increases, the company can still drive overall revenue growth.
View narrative
SEK 38.04
FV
24.6% undervalued
intrinsic discount
3.15%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
23
users have followed this narrative
Updated
narrative
JB Hi-Fi
RO
Robbo
Community Contributor
Has JB Hi-Fi Lost Its Point of Difference?
I may be showing my age here, but I feel that a decade or so ago, shopping at JB Hi-Fi was a different experience. There seemed to be a deliberate policy of employing sales staff from alternative subcultures, which gave the stores a unique, edgy vibe.
View narrative
AU$76.00
FV
51.4% overvalued
intrinsic discount
-0.45%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
GeneDx Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Expanding Pediatric Genomics Will Transform Rare Disease Diagnostics
Key Takeaways Accelerating adoption of genomics in pediatrics and enhanced AI platforms drive growth, efficiency, and margin improvement while reinforcing competitive advantage. Increasing reimbursement, enriched rare disease datasets, and global biopharma partnerships support recurring revenues, premium pricing, and high barriers to entry.
View narrative
US$115.29
FV
9.5% overvalued
intrinsic discount
19.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
19
users have followed this narrative
12 days ago
author updated this narrative
Aurora Cannabis
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
European And Australian Medical Cannabis Markets Will Unlock Enduring Potential
Key Takeaways Strategic focus on high-margin international medical cannabis and operational efficiencies strengthens profitability, margins, and resilience against market entry barriers. Strong financial flexibility and regulatory expertise position Aurora for expansion, market consolidation, and growth without resorting to shareholder-dilutive funding.
View narrative
CA$7.93
FV
7.6% undervalued
intrinsic discount
5.32%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
35
users have followed this narrative
12 days ago
author updated this narrative
Gevo
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Low-Carbon Aviation And Carbon Credits Will Redefine Future Markets
Key Takeaways Rising demand for sustainable aviation fuel, carbon credits, and compliance software positions Gevo for diversified, high-margin growth and reduced revenue volatility. Proprietary technologies, major partnerships, and scalable infrastructure bolster cost competitiveness, operating leverage, and earnings potential amid increasing global decarbonization efforts.
View narrative
US$5.55
FV
68.1% undervalued
intrinsic discount
33.82%
Revenue growth p.a.
Set Fair Value
2
users have liked this narrative
0
users have commented on this narrative
71
users have followed this narrative
12 days ago
author updated this narrative
ONC
BeOne Medicines
AN
AnalystConsensusTarget
Consensus Narrative from 24 Analysts
Oncology Trials And Global Expansion Will Unlock Future Markets
Key Takeaways Rapid commercial expansion and innovative therapies drive sustained growth, with a strong product pipeline supporting future revenue and margin improvement. Operational efficiencies and new product formulations position the company for enhanced profitability and resilience against external cost pressures.
View narrative
US$357.27
FV
13.5% undervalued
intrinsic discount
18.44%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
12 days ago
author updated this narrative
HubSpot
AN
AnalystConsensusTarget
Consensus Narrative from 33 Analysts
Integrated Cloud Platforms And AI Will Expand Global Reach
Key Takeaways Expansion into integrated cloud platforms, AI capabilities, and upmarket enterprise clients is driving higher recurring revenue, larger deals, and improved margins. Accelerated international growth and adaptation to evolving buyer behavior are broadening customer reach and supporting durable, long-term business expansion.
View narrative
US$695.80
FV
34.3% undervalued
intrinsic discount
17.05%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
42
users have followed this narrative
12 days ago
author updated this narrative
LifeMD
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Expanding Care Domains And Telemedicine Will Unlock New Markets
Key Takeaways Expansion into new care areas and insurance partnerships broadens market reach, reduces concentration risk, and supports stability in patient acquisition and revenue. Enhanced AI integration and the subscription-based care model improve operational efficiency, patient retention, and margin growth through automation and recurring revenue streams.
View narrative
US$12.88
FV
51.9% undervalued
intrinsic discount
14.64%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
16
users have followed this narrative
12 days ago
author updated this narrative
Toast
AN
AnalystConsensusTarget
Consensus Narrative from 24 Analysts
Integrated Digital Payments And Automation Will Unlock Future Opportunities
Key Takeaways Expanding digital solutions and automation drive increased market share, recurring revenues, and operational efficiency for restaurants upgrading from legacy systems. New market entries, product upselling, and strategic partnerships diversify revenue streams and deepen customer loyalty, boosting earnings resilience.
View narrative
US$50.33
FV
12.8% undervalued
intrinsic discount
17.34%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
46
users have followed this narrative
12 days ago
author updated this narrative
Rocket Lab
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
Integrated Space Capabilities Will Capture National Security Contracts
Key Takeaways Expanded vertical integration and end-to-end space solutions position Rocket Lab for major defense contracts and future margin growth. High launch cadence, satellite manufacturing, and reusable rocket development enable multi-year revenue growth, backlog expansion, and broader market access.
View narrative
US$45.40
FV
6.0% overvalued
intrinsic discount
37.47%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
192
users have followed this narrative
12 days ago
author updated this narrative
Allbirds
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Sustainable Footwear Launches And Distributor Shift Will Expand Future Presence
Key Takeaways New product innovations, sustainable material partnerships, and refreshed marketing are set to boost brand appeal, customer engagement, and support higher pricing. Shifting to a distributor model and strict cost management are expected to enhance profitability, free up capital, and widen margins despite short-term challenges.
View narrative
US$11.00
FV
41.1% undervalued
intrinsic discount
3.57%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
12 days ago
author updated this narrative
Value any company in seconds
Popular companies